Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
复制标题
DOI：
10.1016/s0140-6736(03)14567-9
复制
发表时间：
2003-10-18
期刊：
影响因子：
168.9
通讯作者：
Frommhold, H
中科院分区：
文献类型：
--
作者：
Henke, M;Laszig, R;Frommhold, H
贫血与癌症控制不良有关，特别是在接受放射治疗的患者中。我们调查了用依泊苷β纠正贫血是否可以改善头颈部癌患者的根治性放疗结果。方法我们在351例患者中进行了一项多中心、双盲、随机、安慰剂对照试验（血红蛋白
Background Anaemia is associated with poor cancer control, particularly in patients undergoing radiotherapy. We investigated whether anaemia correction with epoetin beta could improve outcome of curative radiotherapy among patients with head and neck cancer.Methods We did a multicentre, double-blind, randomised, placebo-controlled trial in 351 patients (haemoglobin